How is herpes zoster ophthalmicus (shingles of the eye) diagnosed?

Diagnosing Herpes Zoster Ophthalmicus

Herpes zoster ophthalmicus is diagnosed primarily by clinical recognition of the characteristic vesicular dermatomal rash along the ophthalmic division of the trigeminal nerve (V1), combined with ocular findings on slit-lamp examination.

Clinical Diagnostic Criteria

The diagnosis of HZO is typically clinical and based on the following distinctive features 1:

Pathognomonic Skin Findings

• Vesicular dermatomal rash or ulceration of the eyelids (often with severe pain)
• Unilateral distribution following the V1 dermatome
• Rash evolution: erythematous maculopapular → clear vesicles → pustulation → scabbing over 3-5 days
• Hutchinson's sign: vesicles on the tip or side of the nose (indicating nasociliary nerve involvement and higher risk of ocular complications)

Ocular Examination Findings

On slit-lamp biomicroscopy, look for 1:

• Bulbar conjunctival injection with watery discharge
• Mild follicular reaction of the conjunctiva
• Pleomorphic or nonexcavated pseudodendritic epithelial keratitis (distinguishes from HSV which has excavated dendrites)
• Punctate keratitis (primary disease) or pseudodendritic keratitis (recurrent disease)
• Palpable preauricular lymph node
• Limbal vesicles (especially in primary infection)

Laboratory Confirmation

Laboratory testing is reserved for atypical presentations or when the diagnosis is uncertain 2, 3:

When to Order Testing

• Absence of characteristic rash
• Immunocompromised patients with atypical presentations
• Need to differentiate from HSV
• Medicolegal documentation requirements

Available Tests

• PCR of vesicle fluid or corneal scraping: Most sensitive and specific method
• Immunohistochemistry: Direct fluorescent antibody testing of vesicle scrapings
• Viral culture: Less sensitive, takes longer, generally not recommended for routine diagnosis

Critical Pitfall to Avoid

Do not wait for laboratory confirmation to initiate treatment. The diagnosis is clinical, and antiviral therapy must be started within 72 hours of rash onset to prevent vision-threatening complications 1, 4. Approximately 50% of HZO patients develop ocular involvement, and up to 25% develop chronic or recurrent disease 5.

Imaging Considerations

High-resolution MRI is indicated only when patients present with acute neuro-ophthalmologic symptoms such as ophthalmoplegia, vision loss, or suspected vasculopathy 6. Standard HZO diagnosis does not require imaging.

MRI Findings When Indicated

• Optic perineuritis (60% of cases with neuro-ophthalmic symptoms)
• Extraocular muscle inflammation (myositis)
• Cavernous sinus enhancement
• Vessel-wall enhancement (VZV vasculopathy)

Diagnostic Algorithm

1. Identify dermatomal vesicular rash in V1 distribution with severe pain
2. Perform slit-lamp examination looking for pseudodendritic keratitis and conjunctival findings
3. Check for Hutchinson's sign (nasal tip involvement)
4. Initiate antiviral therapy immediately without waiting for laboratory confirmation
5. Order PCR or immunohistochemistry only if diagnosis uncertain or presentation atypical
6. Obtain urgent ophthalmology consultation if any ocular involvement suspected
7. Consider HR-MRI only if neuro-ophthalmologic deficits present (ophthalmoplegia, vision loss, stroke symptoms)

The key distinction from HSV is the dermatomal distribution, severe pain, and nonexcavated pseudodendrites rather than true excavated dendrites 1. Unlike HSV which can be bilateral in immunocompromised patients, HZO remains characteristically unilateral even in immunosuppressed individuals.